Pre-made Tamrintamab Pamozirine benchmark antibody (Whole mAb ADC, anti-DPEP3 therapeutic antibody, Anti-MBD3 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-1006

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-1006 Category Tag

Product Details

Pre-made Tamrintamab Pamozirine benchmark antibody (Whole mAb ADC, anti-DPEP3 therapeutic antibody, Anti-MBD3 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Tamrintamab Pamozirine Biosimilar, Whole Mab Adc, Anti-Dpep3 Antibody: Anti-MBD3 therapeutic antibody Drug Conjugate

INN Name

tamrintamab pamozirine

Target

DPEP3

Format

Whole mAb ADC

Derivation

Humanized

Species Reactivity

Human

CH1 Isotype

IgG1 – kappa

VD LC

IgG1 – kappa

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

AbbVie?Inc. (North Chicago IL USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

DPEP3

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide